Our Geno1® technology enables unprecedented advantages in the domain of liquid biopsies and beyond, by reducing costs and thus making next-generation diagnostic solutions accessible for any and all patients.
Liquid biopsies are part of a growing megatrend in cancer diagnostics, permitting non-invasive precision diagnostics and early detection of cancer. These novel diagnostic and therapeutic solutions are increasingly important in our aging societies. However, they are still non-accessible for the big majority of patients and there is room for improvement.
Our Geno1® technology derives from world class academic research conducted at MIT in US and ETH Zurich in Switzerland, latter generously supported by Bill & Melinda Gates Foundation.
The technology truly enables unprecedented scaling of liquid biopsies and beyond, by tackling the three main drivers: cost, accuracy and scalability.
CTO, SCIENTIFIC
Expert in molecular biology, next-generation DNA sequencing and bioinformatics • Post-doctoral experience at MIT and ETH Zurich • Startup experience at a Harvard Medical School spin-off specializing in single cell transcriptomics
CEO, COMMERCIAL
Experienced medtech & life science professional – with several years global experience in commercial functions LATAM, Switzerland, Nordics. • M.Sc Economics Sciences, M.Sc International Politics
MEDICAL ADVISOR,
QUALITY, COMMERCIAL
MD, PhD in cardiology
• International experience in clinical research functions & quality
• Big pharma and clinical background
MEDICAL ADVISOR,
CLINICAL EXPERT
Experienced pediatric pathologist
• Pediatric diseases and cancer
• 84 scientific publications
• Associate Professor
BOARD MEMBER
Master of Laws (LL.M)
• Several years experience in life science and biotech
• Specialities: M&As, startups, IPR
SCIENTIFIC ADVISOR
Professor of Human Genomics at University of Tartu
• Head of Estonian Biobank Innovation Center
• Research Scientist at Broad Institute of MIT and Harvard
• Co-author in 350+ scientific publications
• Among the 250 most influential scientist in the fields of molecular biology and genetics
COPYRIGHT 2021 GENOMILL HEALTH OY | BUSINESS ID 2727877-4